{"id":1426,"date":"2019-04-17T18:11:00","date_gmt":"2019-04-17T18:11:00","guid":{"rendered":"https:\/\/coolblues.bcmultistaging.wpenginepowered.com\/?p=1426"},"modified":"2026-11-04T21:35:25","modified_gmt":"2026-11-04T21:35:25","slug":"oral-immunotherapy-safe-preschool-aged-children-peanut-allergies","status":"publish","type":"post","link":"https:\/\/www.bcchr.ca\/foodallergy\/2019\/04\/17\/oral-immunotherapy-safe-preschool-aged-children-peanut-allergies\/","title":{"rendered":"Oral immunotherapy safe for preschool-aged children with peanut allergies"},"content":{"rendered":"<p class=\"fndry-paragraph\">New data published today in the&nbsp;<em><a href=\"https:\/\/www.jaci-inpractice.org\/article\/S2213-2198(19)30383-6\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener\">Journal of Allergy and Clinical Immunology: In Practice<\/a><\/em>&nbsp;suggests that oral immunotherapy is safe for preschool-aged children with peanut allergies.<\/p>\n\n<p class=\"fndry-paragraph\">The research, led by scientists and pediatric allergists at the University of British Columbia and BC Children\u2019s Hospital, is the first to demonstrate the safety of peanut oral immunotherapy for a large group of preschool-aged children when offered as routine treatment in a hospital or clinic rather than within a clinical trial.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cAlthough there have been many clinical trials of peanut oral immunotherapy in older children, and one trial in preschoolers, there has been a lack of real-world data due to safety concerns of offering this treatment to preschoolers outside of a research setting,\u201d said Lianne Soller, the study\u2019s lead author and allergy research manager at BC Children\u2019s Hospital.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cBut our findings confirm in a real-world setting that this treatment is not only safe but is well-tolerated in a large group of preschool-aged children.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Oral immunotherapy (OIT) is a treatment protocol in which a patient consumes small amounts of an allergenic food, such as peanut, with the dose gradually increased to a determined maximum amount. The goal typically is to reach desensitization, where a patient can ingest more of the allergenic food without triggering a dangerous reaction\u2014protecting them in the event of accidental exposure. Patients must continue to consume a determined amount of the allergen regularly as maintenance.<\/p>\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Is oral immunotherapy safe for preschool-aged children with peanut allergies?\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/tNBHRGEbzM8?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n<h2 class=\"fndry-heading\">Preschool children likely less fearful of their food allergens<\/h2>\n\n<p class=\"fndry-paragraph\">Allergists from across Canada followed 270 children who were given OIT for peanut allergy from April 2017 to November 2018. Children were between the ages of nine months and five years, and all were required to have a convincing diagnosis of peanut allergy made by an allergist.<\/p>\n\n<p class=\"fndry-paragraph\">The team focused on preschool-aged children specifically after the publication of a clinical trial in 2017 showing safety and effectiveness of peanut OIT in 37 children. In addition, there is evidence that young children may be less fearful of their food allergens and their immune systems may be more easily altered than older children.<\/p>\n\n<p class=\"fndry-paragraph\">Children were seen by a pediatric allergist in a community or hospital clinic approximately every two weeks, where they were fed a peanut dose that gradually increased at every visit. Parents also gave children the same daily dose at home, between clinic visits, until they reached a maintenance dose of 300 mg of peanut protein over eight to 11 clinic visits.<\/p>\n\n<p class=\"fndry-paragraph\">Symptoms and treatment of allergic reactions at clinic visits and at home, including epinephrine use, were recorded in the patient\u2019s medical chart. Parents were also provided with instructions on how to manage at-home allergic reactions, when to administer epinephrine, and when to hold off on an OIT dose, such as during a severe cold or flu.<\/p>\n\n<h2 class=\"fndry-heading\">Most children given OIT reached maintenance stage<\/h2>\n\n<p class=\"fndry-paragraph\">The researchers found that 243 children (90 per cent) reached the maintenance stage successfully, while 27 children, or 10 per cent, dropped out. Reasons for dropping out included repeated allergic reactions, the child refusing to consume the daily dose, and parental anxiety. It took an average duration of 22 weeks of oral immunotherapy for patients to reach the maintenance stage.<\/p>\n\n<p class=\"fndry-paragraph\">Although nearly 68 per cent of preschoolers experienced at least one allergic reaction during the build-up phase, the researchers found the majority of reactions were mild (36.3 per cent) or moderate (31.1 per cent). Only 0.4 per cent of children experienced a severe reaction and 11 children (four per cent) received epinephrine.<\/p>\n\n<p class=\"fndry-paragraph\">This study\u2019s findings build on a 2017 randomized clinical trial of 37 preschoolers receiving OIT. None of the children involved in that study experienced a severe reaction. However, the smaller study may have been too small to enable detection of a severe reaction, which the researchers believe may account for the 0.4 per cent experiencing severe reactions in this new study.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cThe goal of our project was to confirm the safety of preschool peanut OIT in a much larger sample of patients in the real world,\u201d said <a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/edmond-chan\/\" target=\"_blank\" rel=\"noopener\">Dr.\u00a0Edmond Chan<\/a>, the study\u2019s senior author. \u201cWe were impressed that among over 40,000 doses of peanut that were administered, only 12 resulted in reactions requiring epinephrine.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Dr. Chan, a pediatric allergist who is also the head of the division of allergy and immunology at UBC and a clinical investigator at the BC Children\u2019s Hospital, said he hopes the findings provide guidance to health-care practitioners treating preschool children in their clinics.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cMany allergists do not believe OIT should be offered outside of research settings, and have not routinely offered it as a therapy for peanut allergy in their clinics due to safety concerns,\u201d he said.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cWe hope that our data demonstrates that the treatment is safe in preschoolers, and could be offered to families of preschool children with peanut allergy who ask for it. There appears to be a big difference in outcomes in preschoolers compared to older children.\u201d<\/p>\n\n<h2 class=\"fndry-heading\">\u2018Having a child with serious allergies can be very socially isolating\u2019<\/h2>\n\n<p class=\"fndry-paragraph\">Ravinder Dhaliwal\u2019s daughter Saiya was one of the patients offered OIT as part of this research. At 10 months old, Saiya broke out in hives when she tried peanuts for the first time. As a pediatric nurse, Dhaliwal immediately knew her daughter likely had a peanut allergy. Further testing confirmed Saiya was allergic to peanuts along with many tree nuts.<\/p>\n\n<p class=\"fndry-paragraph\">Last year, Saiya received OIT for peanut allergies with Chan at BC Children\u2019s Hospital. She responded well to the treatment, even asking Chan to put her on an accelerated schedule, and he agreed because she was responding so well.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cSaiya shows why OIT works so well in preschoolers,\u201d said Dhaliwal. \u201cShe\u2019s very fortunate to have never had an anaphylactic reaction to peanut, so she has no fear or anxiety. She was excited to go through the program. She\u2019d ask me all the time, \u2018when can I eat a peanut butter sandwich?\u2019\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Now five years old, Saiya is also in the final stages of OIT for tree nuts, for which there is even less experience in clinical practice.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cIt blows my mind to think about how far we\u2019ve come,\u201d said Dhaliwal.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cHaving a child with serious allergies can be very socially isolating. Now we can go to potlucks, we can go to restaurants, we can go to friends\u2019 houses, and we don\u2019t have to worry about accidental exposure. It\u2019s been very freeing.\u201d<\/p>\n\n<h2 class=\"fndry-heading\">\u2018We don\u2019t have to live in fear anymore\u2019<\/h2>\n\n<p class=\"fndry-paragraph\">Clementine Cheng knew her daughter Tryphaena was at a high risk for food allergies because her older child had serious allergies to peanuts and tree nuts. When Tryphaena developed hives after eating a granola bar when she was a year old, Clementine\u2019s concerns were confirmed.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cI didn\u2019t have much hope,\u201d said Cheng. \u201cI assumed she\u2019d be allergic for the rest of her life.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">More than a year ago, Tryphaena, now six, started the OIT program at BC Children\u2019s Hospital and has responded well. Soon, she\u2019ll have one more test of eating a large amount of peanuts in the clinic (an oral challenge) to see if she reacts. If she doesn\u2019t, she\u2019ll be considered fully desensitized to peanuts.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cIt\u2019s very emotional to see your child ingesting nuts without having a reaction,\u201d said Cheng. \u201cIt\u2019s been really exciting to be able to offer her different foods without worrying about an accidental exposure. We don\u2019t have to live in fear anymore.\u201d<\/p>\n\n<h2 class=\"fndry-heading\">Future goals of the research<\/h2>\n\n<p class=\"fndry-paragraph\">The data were collected as part of a Canada-wide collaboration between allergy researchers and community allergists called the Canadian Preschool Peanut Oral Immunotherapy (CPP-OIT) project.<\/p>\n\n<p class=\"fndry-paragraph\">The group now hopes to investigate the long-term safety and efficacy of peanut OIT desensitization and sustained unresponsiveness for patients who choose to stop daily peanut OIT.<\/p>","protected":false},"excerpt":{"rendered":"<p>New data published today in the Journal of Allergy and Clinical Immunology: In Practice suggests that oral immunotherapy is safe for preschool-aged children with peanut allergies.<\/p>\n","protected":false},"author":2,"featured_media":1904,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","inline_featured_image":false,"footnotes":"","fndry_alternate_title":""},"categories":[10],"tags":[],"class_list":["post-1426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"modified_by":"Andrea Sakamoto","_links":{"self":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/comments?post=1426"}],"version-history":[{"count":3,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1426\/revisions"}],"predecessor-version":[{"id":2464,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/posts\/1426\/revisions\/2464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/media\/1904"}],"wp:attachment":[{"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/media?parent=1426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/categories?post=1426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bcchr.ca\/foodallergy\/wp-json\/wp\/v2\/tags?post=1426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}